HOME
BUSINESS
MARKETS
BIOTECH
LIFESTYLE
TRENDING
Search
Financial Trends
HOME
BUSINESS
MARKETS
BIOTECH
LIFESTYLE
TRENDING
Tag: NASDAQ:SNTA
Health
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Director Sells Over 3 Million Shares In...
Aaron Lyons
-
Business
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Cites Review For HSP90
Aaron Lyons
-
Health
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) To Report Q1 Results On May 8,...
Brandon Manns
-
Health
Synta Pharmaceuticals Corp (NASDAQ:SNTA)’s CEO Resigns
Aaron Lyons
-
Health
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) launches clinical trial for “GANNET53”
Neha Rathod
-
Health
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Stock Trading Up By 15.15%
Brandon Manns
-
Health
Synta Pharmaceuticals Corp (NASDAQ:SNTA)’s shares rose by 6.55% on Friday
Brandon Manns
-
Health
Synta Pharmaceuticals Corp. (NASDAQ:SNTA)’s stock gains 23%
Aaron Lyons
-
Health
Synta Pharmaceuticals Corp. (NASDAQ:SNTA): Ganetespib Guides the Future
Rebecca Harrison
-
Business
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) focus on treatment of cancer and in...
Neha Rathod
-
